ERBB2 and breast carcinoma: The phenolic compound nordihydroguaiaretic acid (NDGA) suppressed IGF-IR and HER2 signaling [45, 46], and induced cell death of trastuzumab-naive and trastuzumab-refractory HER2-over-expressing breast cancer cells [45].